The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper GI Bleeding
THE DIFFERENCE IN CARBON FOOTPRINT BETWEEN DIAGNOSTIC UPPER GI ENDOSCOPY IN DYSPEPTIC PATIENTS VERSUS THERAPEUTIC UPPER GI BLEEDING
King Chulalongkorn Memorial Hospital
75 participants
Jun 1, 2025
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to learn about the carbon footprint produced from diagnostic upper GI endoscopy in patients with dyspepsia and therapeutic upper GI endoscopy in patients with non-variceal upper GI bleeding. The main question it aims to answer is: • How much carbon footprint is generated from upper GI endoscopy Participants are already receiving diagnostic and therapeutic upper GI endoscopy as part of their regular medical care for dyspepsia and non-variceal upper GI bleeding, respectively. The carbon footprint generated from this treatment process is examined.
Eligibility
Inclusion Criteria5
- Patients with dyspepsia or non-variceal upper GI bleeding
- Age 20-80 years
- Body mass index of 30 or less;
- Receiving one of the following procedure during upper GI endoscopy:
- For diagnostic endoscopy: Rapid urease test for H. pylori infection For therapeutic endoscopy: stop bleeding with either Argon plasma coagulation or Bipolar hemostasis probe or Hemostasis clip
Exclusion Criteria6
- Platelet \< 50,000
- INR \> 2.5
- Pregnancy
- History of allergy to IV sedative medication
- Peptic ulcer grade IIc and III according to Forrest classification
- Patient receiving inhalation anesthesia
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07261228